Product Information
LORATADINE 5 MG/5 ML SOLUTION is a generic product labeled by BluePoint Laboratories, priced at $0.0414 per ML under NDC 68001044998. Its NADAC has been published 275 times since Jun 30, 2021.
FDA first approved this application on Jun 29, 2018.
Strength
5 mg/5mL
Manufacturer
BluePoint LaboratoriesNDC
68001044998
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LORATADINEApproval Type
Generic (ANDA)
FDA Application
ANDA208931FDA Approved
6/29/2018
On Market Since
7/31/2020
Price Statistics
The NADAC for LORATADINE 5 MG/5 ML SOLUTION has been published 275 times since Jun 30, 2021, and over the history we have for it it has risen 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0414 per ML |
|---|---|
| All-time high | $0.0471 (Dec 14, 2022) |
| All-time low | $0.0338 (Nov 20, 2024) |
| 52-week high | $0.0428 |
| 52-week low | $0.0393 |
| Median price | $0.0416 |
| Average price | $0.0415 |
| Largest weekly change | +25.7% (Aug 21, 2024) |
| Weeks tracked | 275 |
| Tracking since | Jun 30, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Loratadine Oral market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loratadine Oral market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LORATADINE 5 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for LORATADINE 5 MG/5 ML SOLUTION, manufactured by BluePoint Laboratories, is $0.0414 per ML (NDC 68001044998), effective Sep 30, 2026.
How has the price of LORATADINE 5 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for LORATADINE 5 MG/5 ML SOLUTION has risen 2.6%. It has been tracked across 275 weekly CMS publications since Jun 30, 2021.
What are the highest and lowest recorded NADAC prices for LORATADINE 5 MG/5 ML SOLUTION?
Since Jun 30, 2021, the NADAC for LORATADINE 5 MG/5 ML SOLUTION has ranged from a low of $0.0338 (Nov 20, 2024) to a high of $0.0471 (Dec 14, 2022), with a median of $0.0416 per ML.
Are there cheaper alternatives to LORATADINE 5 MG/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of LORATADINE 5 MG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LORATADINE 5 MG/5 ML SOLUTION?
LORATADINE 5 MG/5 ML SOLUTION (NDC 68001044998) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.